Shanghai Haohai Biological Technology reports H share repurchase activity

Shanghai Haohai Biological Technology disclosed a repurchase of 47,100 H shares on November 20, 2025, conducted on the Hong Kong Stock Exchange. The shares were repurchased at prices ranging from HK$27.1 to HK$27.54 per share, totaling HK$1,287,612. Following this transaction, the company's total issued H shares remain at 38,529,240, with no change in treasury H shares, which stood at 0.

The repurchase is part of a larger authorization approved on June 10, 2025, which allows the company to repurchase up to 3,914,184 shares. To date, 1,066,800 shares have been repurchased under this authorization, representing 2.7255% of the company's issued shares (excluding treasury shares) as of the authorization date. A temporary suspension on new share issuance, treasury share sales, or transfers is in effect until December 20, 2025.

The company's total issued A shares on the Shanghai Stock Exchange remain unchanged at 190,203,760, with 3,848,095 A shares held in treasury. The combined total issued shares (excluding treasury shares) for both A and H shares is 228,733,000.